Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hoots

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|February 15, 2001
Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacsE S Daar, H Lynn, S Donfield, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Hemophilia growth and development study. Design, methods, and entry dataM W Hilgartner, S M Donfield, A Willoughby, et al.
Neurosurgery|July 1, 1984
Clinicopathological correlations of disseminated intravascular coagulation in patients with head injuryH H Kaufman, K S Hui, J C Mattson, et al.
Biological Psychiatry|April 20, 2020
In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain HypoxiaJennifer M Bossert, Eugene A Kiyatkin, Hannah Korah, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
Lancet (London, England)|July 2, 2002
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over studySaroj Vadhan-Raj, John J Kavanagh, Ralph S Freedman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 30, 2009
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) projectR Kulkarni, J M Soucie, J Lusher, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Applied Neuropsychology. Adult|April 24, 2024
Empirically derived symptom profiles in adults with attention-Deficit/hyperactivity disorder: An unsupervised machine learning approachVioleta J Rodriguez, John-Christopher A Finley, Qimin Liu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|February 15, 2001
Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacsE S Daar, H Lynn, S Donfield, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Hemophilia growth and development study. Design, methods, and entry dataM W Hilgartner, S M Donfield, A Willoughby, et al.
Neurosurgery|July 1, 1984
Clinicopathological correlations of disseminated intravascular coagulation in patients with head injuryH H Kaufman, K S Hui, J C Mattson, et al.
Biological Psychiatry|April 20, 2020
In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain HypoxiaJennifer M Bossert, Eugene A Kiyatkin, Hannah Korah, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
Lancet (London, England)|July 2, 2002
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over studySaroj Vadhan-Raj, John J Kavanagh, Ralph S Freedman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 30, 2009
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) projectR Kulkarni, J M Soucie, J Lusher, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Applied Neuropsychology. Adult|April 24, 2024
Empirically derived symptom profiles in adults with attention-Deficit/hyperactivity disorder: An unsupervised machine learning approachVioleta J Rodriguez, John-Christopher A Finley, Qimin Liu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Pageof 10